Altimmune, Inc. — Director's Dealing 2010

May 17, 2010

SEC Form 4/A — Form 4/A

Issuer: PHARMATHENE, INC (PIP)
CIK: 0001326190
Period of Report: 2010-05-06

Reporting Person: Fusco Joan (SVP, Operations)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-05-06	Stock Option (right to buy)	$1.38	A	10000	Acquired	2020-05-06	Common Stock (10000)	Indirect

Footnotes

F1: The option vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant
date.

F2: On May 6, 2010, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.38
per share.

F3: This Amendment to Form 4 is being filed to report an option to purchase 10,000 shares granted to the Reporting Person's
spouse, a non-executive employee of the Issuer. This option was not previously reported on the Reporting Person's Form 4
filed on May 10, 2010.